Best Type of Exercise

From eNewsletter 6/17/2026

DID YOU KNOW that there is a new name for polycystic ovarian syndrome (PCOS), according to a study from The Lancet? It is now called polyendocrine metabolic ovarian syndrome (PMOS).

According to the authors, the term PCOS is inaccurate, implying pathological ovarian cysts, obscuring diverse endocrine and metabolic features, and contributing to delayed diagnosis, fragmented care, and stigma, while curtailing research and policy framing.

Building on an international mandate for change, the authors outlined an unprecedented, rigorous, multistep global consensus process for the name change. Funding and governance were established with engagement of 56 leading academic, clinical, and patient organizations.

Using global surveys (with responses from 14 360 people with PCOS and multidisciplinary health professionals from all world regions), modified Delphi methods, nominal group technique workshops, and marketing and implementation analyses, they identified principles prioritizing scientific accuracy, clarity, stigma avoidance, cultural appropriateness, and implementation feasibility. An accurate new name was prioritized over retaining the PCOS acronym or a generic name.

To read the rest of today's issue, please go to this page.